Patterns of care and clinical outcomes with cytarabine-anthracycline induction chemotherapy for AML patients in the United States

Cytarabine-anthracycline based intensive induction chemotherapy (IC) remains the standard of care for remission induction among fit patients with newly diagnosed acute myeloid leukemia (AML) in the United States (US). However, the mortality rate outside of clinical IC trials, predictors of death, an...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Blood Adv
Hauptverfasser: Zeidan, Amer M., Podoltsev, Nikolai A., Wang, Xiaoyi, Zhang, Chi, Bewersdorf, Jan Philipp, Shallis, Rory M., Huntington, Scott F., Neparidze, Natalia, Giri, Smith, Gore, Steven D., Davidoff, Amy J., Ma, Xiaomei, Wang, Rong
Format: Artigo
Sprache:Inglês
Veröffentlicht: American Society of Hematology 2020
Schlagworte:
Myeloid Neoplasia
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7189301/
https://ncbi.nlm.nih.gov/pubmed/32311013
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020001728
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge